To investigate whether the increase in peptide–MHC-I complexes induced by BLM enhanced CD8+ T cell activation and tumor-killing capability, we conducted a coculture assay of B16OVA tumor cells and OT-I T cells. This evidence concerns the gene CD8A and neoplasm.